Minerva Neurosciences, Inc.

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: US6033802058

USD

3.74

0.49 (15.08%)

Dec 04

NAS

Click here to see other stocks

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Xilio Therapeutics, Inc.

Veru, Inc.

Outlook Therapeutics, Inc.

Societal CDMO, Inc.

Clearside Biomedical, Inc.

Immunic, Inc.

Adicet Bio, Inc.

Clene, Inc.

Minerva Neurosciences, Inc.

Ampio Pharmaceuticals, Inc.

SciSparc Ltd.

Why is Minerva Neurosciences, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Minerva Neurosciences, Inc. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Minerva Neurosciences, Inc.

70.01%

0.09

176.59%

S&P 500

13.22%

0.61

20.17%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-100.00%

EBIT Growth (5y)

-14.89%

EBIT to Interest (avg)

-14.70

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.46

Sales to Capital Employed (avg)

0.91

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

37.89%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

-0.44

EV to EBIT

-2.91

EV to EBITDA

-2.91

EV to Capital Employed

4.12

EV to Sales

PEG Ratio

0.02

Dividend Yield

ROCE (Latest)

-141.66%

ROE (Latest)

Negative BV

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

Bearish

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD -15.63 MM

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

OPERATING PROFIT(Q)

Highest at USD -3.37 MM

PRE-TAX PROFIT(Q)

At USD -3.26 MM has Grown at 60.42%

NET PROFIT(Q)

At USD -3.26 MM has Grown at 60.42%

-1What is not working for the Company

CASH AND EQV(HY)

Lowest at USD 32.74 MM

Here's what is working for Minerva Neurosciences, Inc.

Operating Cash Flow

Highest at USD -15.63 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Operating Profit

Highest at USD -3.37 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (USD MM)

Pre-Tax Profit

At USD -3.26 MM has Grown at 60.42%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit

At USD -3.26 MM has Grown at 60.42%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (USD MM)

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Minerva Neurosciences, Inc.

Cash and Eqv

Lowest at USD 32.74 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents